glp 1 agonists natural GLP-1 Alternatives: Supporting Metabolic Health GLP-1 Agonists: A Comprehensive Overview
Description
Sanyal AJ, Kaplan LM, Frias JP, et al
[DOI] [PubMed] [Google Scholar] 76.Zhou W, et al
Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus
Signal 9 , 11 (2011)
Recent studies have found that GLP-1RAs have therapeutic effects on neurological, cardiovascular, endocrine and metabolic diseases
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
